Recently, Dr. Sun Yimin, President of CapitalBiotech, along with Dr. Li Yanze, Assistant President, visited Kyrgyzstan to hold a working meeting with officials from the Chinese Embassy in Kyrgyzstan. During the same period, at the 19th MedExpo Kyrgyzstan, Kanatbek Temirbekovich Bekboyev, Minister of Health of Kyrgyzstan, visited the CapitalBiotech’ booth and held in-depth discussions with Dr. Sun and his delegation, further advancing the construction of the Kyrgyzstan National Precision Medicine Center.
As the joint construction of the Belt and Road Initiative enters a new stage of high-quality development, CapitalBiotech is committed to seizing this opportunity and working closely with Kyrgyz partners to steadfastly promote high-quality cooperation under the BRI framework.
Development of Transcriptome Sequencing TechnologyApril 4, 2023Transcriptome refers to the total sum of all expressed genes in a specific cell under specific functional conditions, which includes all transcript information of a cell. Typically, transcriptome anal...view
Microbial Genome Sequencing's Impact on AgricultureFebruary 26, 2024Microbial genome sequencing has revolutionized the field of agriculture by providing valuable insights into the genetic makeup of microorganisms that play a crucial role in soil health, plant growth, ...view
Basic Performance of In Vitro Diagnostic Reagent ProductsMarch 9, 20231. Blank IVD in vitro diagnostic reagentsThe reagent blank can be understood as the value detected when the content of the substance to be tested is the theoretical zero value. The general practice is...view
Is a Microarray Platform Right for Gene Expression?November 10, 2023When it comes to gene expression analysis, microarray platforms are a popular choice for researchers around the world. But is a microarray platform right for your specific needs? In this article, we w...view